P033 population-level hpv vaccination coverage among u.s. adult ibd patients: still not enough

Evidence suggests that the inflammatory bowel disease (IBD) patients may have an elevated risk of Human papillomavirus (HPV)-associated cancers when compared with those without IBD. HPV vaccination has been recommended for 11 to 26 years old males and females. Recently, the Centers for Disease Control and Prevention (CDC) has updated the guideline to include adults aged 27 to 45 who are not adequately vaccinated. To the best of our knowledge, population-level HPV vaccine uptake rates among patients with IBD remains unknown.

Source: Gastroenterology - January 25, 2020 Category: Gastroenterology Authors: Ryan Suk, Heetae Suk, Keith Sigel, Kalyani Sonawane, Ashish Deshmukh Tags: Quality of Life/Psychosocial Care Source Type: research